About

As the global population ages and emerging markets seek improved health care, the medical technologies and pharmaceuticals (MTP) sector is growing fast. According to CSIRO’s MTP Roadmap it’s expected to be worth almost $3 trillion globally by 2025.

Australia is home to more than 500 companies working in the MTP sector. Many of these are small and medium enterprises, which sometimes struggle to transition from the R&D phase, towards a biomedical product for clinical trials.

CSIRO’s Biomedical Materials Translational Facility (BMTF) has the equipment, and staff with the expertise and experience, needed to help MedTech companies develop their product at pilot scale, including preparation of materials and devices for preclinical and Phase I clinical trials in Australia.

To find out more about and how to access our facility please see the Services page.